These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 844493)

  • 21. [Effect of prolonged hypokinesia on the biogenic amine content of rat brain synaptosomes].
    Panusheva NN
    Biull Eksp Biol Med; 1983 Dec; 96(12):12-4. PubMed ID: 6686464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes.
    McKillop D; Bradford HF
    Biochem Pharmacol; 1981 Oct; 30(20):2753-8. PubMed ID: 7317073
    [No Abstract]   [Full Text] [Related]  

  • 23. A simple histochemical screening method for amine uptake.
    Mori J; Shimomura K; Saitoh R; Honda F
    Jpn J Pharmacol; 1980 Oct; 30(5):679-87. PubMed ID: 7206374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ORG 6582 on monoamine uptake in vitro.
    Mireylees SE; Goodlet I; Sugrue MF
    Biochem Pharmacol; 1978 Apr; 27(7):1023-7. PubMed ID: 656149
    [No Abstract]   [Full Text] [Related]  

  • 25. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors?
    Raiteri M; Bonanno G; Marchi M; Maura G
    J Pharmacol Exp Ther; 1984 Dec; 231(3):671-7. PubMed ID: 6150107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of viloxazine, its optical isomers and its major metabolites on biogenic amine uptake mechanisms in vitro and in vivo.
    Blackburn TP; Foster GA; Greenwood DT; Howe R
    Eur J Pharmacol; 1978 Dec; 52(3-4):367-74. PubMed ID: 729646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of nefopam and its enantiomers on the uptake of 5-hydroxytryptamine, noradrenaline and dopamine in crude rat brain synaptosomal preparations.
    Rosland JH; Hole K
    J Pharm Pharmacol; 1990 Jun; 42(6):437-8. PubMed ID: 1979627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of monoamine uptake in synaptosomes by tetrahydroharmane and tetrahydroisoquinoline compounds.
    Tuomisto L; Tuomisto J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(4):371-80. PubMed ID: 4150087
    [No Abstract]   [Full Text] [Related]  

  • 29. Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters.
    Yu H; Rothman RB; Dersch CM; Partilla JS; Rice KC
    Bioorg Med Chem; 2000 Dec; 8(12):2689-92. PubMed ID: 11131159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.
    Raiteri M; Bertollini A; Angelini F; Levi G
    Eur J Pharmacol; 1975 Nov; 34(1):189-95. PubMed ID: 1234761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of monoamine uptake into rat brain synaptosomess by selected bicyclo-octanes and an analogous bicyclo-octene.
    Wedley S; Howard JL; Large BT; Pullar IA
    Biochem Pharmacol; 1978; 27(24):2907-9. PubMed ID: 736983
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain.
    Javaid JI; Perel JM; Davis JM
    Life Sci; 1979 Jan; 24(1):21-8. PubMed ID: 763066
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-induced release of biogenic amines from synaptosomes and blood platelets of guinea-pigs.
    Peyer M; Pletscher A; Affolter H
    Neuropharmacology; 1982 Sep; 21(9):831-8. PubMed ID: 6216418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphetamine-antagonistic property of 4-phenyltetrahydroisoquinoline: effect on noradrenaline release in spinal cord slices.
    Satoh M; Ohta S; Nagao T; Hirobe M; Fukuda H; Ono H
    Jpn J Pharmacol; 1992 Oct; 60(2):121-5. PubMed ID: 1479740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic properties of nomifensine.
    Gianutsos G; Morrow G; Light S; Sweeney MJ
    Pharmacol Biochem Behav; 1982 Nov; 17(5):951-4. PubMed ID: 6294689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Para-substituted amphetamines and brain serotonin.
    Magyar K; Knoll J
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):139-43. PubMed ID: 1208223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the rat.
    Keane PE; Kan JP; Sontag N; Benedetti MS
    J Pharm Pharmacol; 1979 Nov; 31(11):752-4. PubMed ID: 41906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo effects of benztropine and nomifensine on dopamine and noradrenaline terminals in rat brain.
    Broch OJ
    Eur J Pharmacol; 1979 Oct; 58(4):419-24. PubMed ID: 510376
    [No Abstract]   [Full Text] [Related]  

  • 39. The inhibition of (3H) biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives.
    Heikkila RE; Cohen G
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):539-47. PubMed ID: 4824828
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of the synaptosomal high-affinity uptake of noradrenaline in the nucleus accumbens of rats.
    Hetey L; Zimmermann B
    Biomed Biochim Acta; 1986; 45(9):1203-7. PubMed ID: 3814110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.